Standard Follow-Up Program (SFP) for Patients With Esophageal Cancer
NCT02454790 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000
Last updated 2024-02-28
Summary
Motive:
In order to improve the treatment technique, a comprehensive follow-up program is needed to obtain all relevant patient, treatment and toxicity data from esophageal cancer patients.
Goal:
To set-up and maintain a database containing treatment results in terms of tumor control, side effects, complications and patient-reported quality of life.
A standard database of patients receiving photon treatment will be created. These data are then linked to dose-volume data of radiotherapy, with the aim to build prediction models for both tumor control and toxicity after radio (chemo) therapy that can later be used for selecting patients for proton treatment.
Conditions
- Esophageal Cancer
Interventions
- RADIATION
-
Radiotherapy
Sponsors & Collaborators
-
University Medical Center Groningen
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-09-30
- Primary Completion
- 2030-01-31
- Completion
- 2030-01-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Functional Imaging to Identify Radiosensitive Esophageal Cancer - a Biomarker Validation Study
NCT06189898 ·Status: RECRUITING
-
Dose Escalation by Boosting Radiation Dose Within the Primary Tumor Using 18FDG-PET/CT for Unresectable Thoracic Esophageal Cancer
NCT01843049 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Complete Clinical Responders to Definite Chemoradiation in Esophageal Cancer : a Survival Analysis
NCT01525953 ·Status: COMPLETED
-
An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
NCT00561197 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Combination of Radiation Therapy and Anti-PD-1 Antibody SHR-1210 in Treating Patients With Esophageal Cancer
NCT03187314 ·Status: COMPLETED ·Phase: PHASE2
-
Defining the Radiotherapy Dose and Volume Parameters Affecting Postoperative Complications in Esophageal Cancer Patients
NCT02323776 ·Status: TERMINATED
-
Surveillance of Patients With Adenocarcinoma of the Gastroesophageal Junction or Esophagus
NCT02991547 ·Status: TERMINATED
-
Concurrent Radiotherapy and Weekly Chemotherapy of PF for Postoperative Locoregional Recurrence of Esophageal Cancer
NCT02325986 ·Status: UNKNOWN ·Phase: PHASE2
-
Phase II Study of Extensive Clinical Target Volumes in Postoperative Radiotherapy for Esophageal Squamous Cell Carcinoma
NCT02384811 ·Status: UNKNOWN ·Phase: PHASE2
-
S-1 and Radiotherapy in Elderly Patients With Esophageal Cancer
NCT01175447 ·Status: COMPLETED ·Phase: PHASE1
-
Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus
NCT00008047 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
OPPOSITE: Outcome Prediction of Systemic Treatment in Esophagogastric Carcinoma
NCT03429816 ·Status: COMPLETED ·Phase: NA
-
Organ Preservation With Durvalumab-based Immunotherapy in Combination With Chemoradiation as Definitive Therapy for Early Stage Esophageal Adenocarcinoma With Indication for Radical Surgery
NCT05713838 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy and Safety Study of the Combined Modality Therapy in Adenocarcinoma of the Esophago-gastric Junction
NCT01523015 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study of 5-FU, Oxaliplatin, & Lapatinib Combined With Radiation Therapy to Treat HER2 Positive Esophagogastric Cancer
NCT01769508 ·Status: TERMINATED ·Phase: PHASE2
-
Perioperative Chemotherapy Compared To Neoadjuvant Chemoradiation in Patients With Adenocarcinoma of the Esophagus
NCT02509286 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
RCT on the Combined Modality Treatment of Squamous Cell Carcinoma of the Esophagus
NCT00559351 ·Status: TERMINATED ·Phase: PHASE3
-
Chemotherapy, Radiation Therapy, and Cetuximab Followed by Surgery, Docetaxel, and Cetuximab in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer
NCT00551759 ·Status: TERMINATED ·Phase: PHASE2
-
Study of Simultaneous Modulated Accelerated Radiation Therapy Concurrent With Chemotherapy to Treat Esophageal Cancer
NCT01670409 ·Status: COMPLETED ·Phase: PHASE2
-
Surgery With or Without Radiation Therapy and Chemotherapy in Treating Patients With Esophageal Cancer
NCT00047112 ·Status: COMPLETED ·Phase: PHASE3
-
Chemotherapy and Radiation Therapy in Treating Patients With Cancer of the Esophagus
NCT00002884 ·Status: UNKNOWN ·Phase: PHASE3
-
Radiation Dose Intensification With Accelerated Hypofractionated Intensity Modulated Radiation Therapy and Concurrent Carboplatin and Paclitaxel for Inoperable Esophageal Cancer
NCT04046575 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Positron Emission Tomography in Determining Stage of Esophageal Cancer
NCT00004867 ·Status: COMPLETED ·Phase: NA
-
Trial of S-1 Maintenance Therapy in Metastatic Esophagogastric Cancer
NCT02128243 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel, Cisplatin, Gefitinib, and Radiation Therapy Followed by Surgery and Gefitinib in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction That Can Be Removed By Surgery
NCT00493025 ·Status: TERMINATED ·Phase: PHASE2